Literature DB >> 6321698

Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus.

R Markstein, T Hökfelt.   

Abstract

The cat caudate nucleus has been reported to possess a rich and fairly even distribution of nerve endings, containing both dopamine- and cholecystokinin-like peptides. In this study, the effect of cholecystokinin-octapeptide (CCK-8) on basal and electrically evoked tritium outflow from slices of cat caudate nucleus previously labeled with [3H]dopamine was examined. Evoked tritium outflow from slices of cat caudate nucleus was Ca2+ dependent and abolished by tetrodotoxin, suggesting that it reflects action potential-induced [3H]dopamine release. In the presence of bovine serum albumin and bacitracin, the sulfated but not the unsulfated form of CCK-8 inhibited both basal and electrically evoked tritium outflow from slices of cat caudate nucleus at very low concentrations. CCK-8 sulfate was efficient in causing this effect in concentrations down to 10(-14) M, and the maximum effect was obtained with 10(-11) M. In contrast, without bovine serum albumin and bacitracin, no inhibitory effect of CCK-8 sulfate was seen, but instead, a marked enhancement of tritium outflow at 10(-7) M was observed. The findings suggest that CCK-8 sulfate in dopamine/CCK coexistence regions is involved in regulating dopamine release.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321698      PMCID: PMC6564911     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

Review 1.  Co-existence between receptors, carriers, and second messengers on astrocytes grown in primary cultures.

Authors:  E Hansson
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

2.  Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies.

Authors:  C A Tamminga; R L Littman; L D Alphs; T N Chase; G K Thaker; A M Wagman
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry.

Authors:  K Seroogy; M Schalling; S Brené; A Dagerlind; S Y Chai; T Hökfelt; H Persson; M Brownstein; R Huan; J Dixon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

4.  Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics.

Authors:  Y Hama; M Ebadi
Journal:  Neurochem Res       Date:  1987-08       Impact factor: 3.996

6.  Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.

Authors:  T Ashizawa; T Saito; N Takahata
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

7.  Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.

Authors:  F H Marshall; S Barnes; R D Pinnock; J Hughes
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

8.  Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.

Authors:  S Tanganelli; K Fuxe; G von Euler; L F Agnati; L Ferraro; U Ungerstedt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

9.  Comparison between radiolabelled and endogenous dopamine release from rat striatal slices: effects of electrical field stimulation and regulation by D2-autoreceptors.

Authors:  H Herdon; S R Nahorski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.